BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16417233)

  • 1. Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma.
    Kohonen-Corish MR; Cooper WA; Saab J; Thompson JF; Trent RJ; Millward MJ
    J Invest Dermatol; 2006 Jan; 126(1):167-71. PubMed ID: 16417233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability.
    Whitehall VL; Walsh MD; Young J; Leggett BA; Jass JR
    Cancer Res; 2001 Feb; 61(3):827-30. PubMed ID: 11221863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
    Kohonen-Corish MR; Daniel JJ; Chan C; Lin BP; Kwun SY; Dent OF; Dhillon VS; Trent RJ; Chapuis PH; Bokey EL
    J Clin Oncol; 2005 Apr; 23(10):2318-24. PubMed ID: 15800322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew M; Smith JL; Jass JR; Young J; Leggett BA; Macdonald GA
    Oncol Rep; 2007 Apr; 17(4):817-22. PubMed ID: 17342321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of O⁶-methyguanine-DNA methyltransferase by promoter hypermethylation: association of epithelial ovarian carcinogenesis in specific histological types.
    Roh HJ; Suh DS; Choi KU; Yoo HJ; Joo WD; Yoon MS
    J Obstet Gynaecol Res; 2011 Jul; 37(7):851-60. PubMed ID: 21450028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis.
    Matsumura S; Oue N; Ito R; Nakayama H; Kitadai Y; Yokozaki H; Chayama K; Yasui W
    Virchows Arch; 2003 Oct; 443(4):518-23. PubMed ID: 12920593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT.
    Christmann M; Pick M; Lage H; Schadendorf D; Kaina B
    Int J Cancer; 2001 Apr; 92(1):123-9. PubMed ID: 11279615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
    Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J
    Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors.
    Yin D; Xie D; Hofmann WK; Zhang W; Asotra K; Wong R; Black KL; Koeffler HP
    Mol Carcinog; 2003 Jan; 36(1):23-31. PubMed ID: 12503076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
    Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on DNA methylation of human osteosarcoma cell MGMT and its relationship with cell resistance to alkylating agents.
    Guo J; Cui Q; Jiang W; Liu C; Li D; Zeng Y
    Biochem Cell Biol; 2013 Aug; 91(4):209-13. PubMed ID: 23859014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
    Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
    J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.
    Zheng CG; Jin C; Ye LC; Chen NZ; Chen ZJ
    Tumour Biol; 2015 Aug; 36(8):5839-48. PubMed ID: 25716203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
    Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
    Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
    Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
    Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
    Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.
    Kewitz S; Stiefel M; Kramm CM; Staege MS
    Leuk Res; 2014 Jan; 38(1):138-43. PubMed ID: 24284332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.